4.6 Article

Glucose and Fatty Acids Synergize to Promote B-Cell Apoptosis through Activation of Glycogen Synthase Kinase 3β Independent of JNK Activation

Journal

PLOS ONE
Volume 6, Issue 4, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0018146

Keywords

-

Funding

  1. National Institutes of Health (NIH) [R37 DK16746, R01 DK33301, RO1 DK64938, P60 DK20579, P30DK056341]
  2. Ministry of Education, Culture, Sports and Science [22590984]
  3. Takeda Science Foundation
  4. Banyu Life Science Foundation Japan
  5. Grants-in-Aid for Scientific Research [23390080, 22590984] Funding Source: KAKEN

Ask authors/readers for more resources

Background: The combination of elevated glucose and free-fatty acids (FFA), prevalent in diabetes, has been suggested to be a major contributor to pancreatic beta-cell death. This study examines the synergistic effects of glucose and FFA on beta-cell apoptosis and the molecular mechanisms involved. Mouse insulinoma cells and primary islets were treated with palmitate at increasing glucose and effects on apoptosis, endoplasmic reticulum (ER) stress and insulin receptor substrate (IRS) signaling were examined. Principal Findings: Increasing glucose (5-25 mM) with palmitate (400 mu M) had synergistic effects on apoptosis. Jun NH2-terminal kinase (JNK) activation peaked at the lowest glucose concentration, in contrast to a progressive reduction in IRS2 protein and impairment of insulin receptor substrate signaling. A synergistic effect was observed on activation of ER stress markers, along with recruitment of SREBP1 to the nucleus. These findings were confirmed in primary islets. The above effects associated with an increase in glycogen synthase kinase 3 beta (Gsk3 beta) activity and were reversed along with apoptosis by an adenovirus expressing a kinase dead Gsk3b beta. Conclusions/Significance: Glucose in the presence of FFA results in synergistic effects on ER stress, impaired insulin receptor substrate signaling and Gsk3 beta activation. The data support the importance of controlling both hyperglycemia and hyperlipidemia in the management of Type 2 diabetes, and identify pancreatic islet beta-cell Gsk3 beta as a potential therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available